Novel anti-inflammatory therapies are therefore being developed as potential therapeutic agents, a recent study [13] showed that an MPO inhibitor is able to stop progression of COPD in an animal model by inhibiting oxidative damage. This evidence concerns the gene MPO and chronic obstructive pulmonary disease.